Enobong Edoabasi Obong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Enobong Edoabasi Obong has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Lawrence John Ajutor
Department of Medical Laboratory Science, University of Benin, Benin City, Edo State
2 shared publications - Opeoluwa Alayande2 shared publications
- Tosin Abiodun Aderanti
Department of Chemical and Environmental Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria
2 shared publications - Ademola Busayo Ajayi
Department of Education and Human Services, School of Educational Foundations, Leadership and Aviation, Oklahoma State University, United States
1 shared publication - Adepeju Kafayat Olowookere
Department of Nanoscience, University of North Carolina at Greensboro, Greensboro, NC, USA
1 shared publication - Adesuwa Erude1 shared publication
Latest Publications
- Open Access
- 13 January 2026
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 2 (1) , aubm012
Gene Editing Therapies for Sickle Cell Disease and β-Thalassemia: A Systematic Review of Clinical Outcomes and Safety
Background: Sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) remain major global health burdens. Ex vivo gene-editing therapies aim to achieve durable fetal hemoglobin (HbF) induction or direct mutation correction. Methods: We systematically reviewed clinical studies of CRISPR-Cas9 or base-editing therapies for SCD and TDT (MEDLINE, EMBASE, Web of Science, ClinicalTrials.gov, conference proceedings; 2010–03 December 2025). Eleven studies (>170 treated patients) reporting post-infusion outcomes were included. Results: All therapies produced robust, pancellular HbF (30–65%) and total hemoglobin in/near the normal range. In TDT (n > 100 evaluable), transfusion independence (≥12 months, Hb ≥9 g/dL) was achieved in 89–100% across platforms, sustained up to >4 years. In SCD (n > 60 evaluable), adjudicated vaso-occlusive crises were eliminated for ≥12 months in ≥97% of patients treated with exagamglogene autotemcel and 100% in smaller cohorts (EDIT-301, BEAM-101). No graft failures occurred. Serious adverse events and one death were attributable to busulfan conditioning, not editing. No therapy-related malignancies or confirmed harmful off-target edits have been reported, although follow-up remains limited (median ~18 months, longest >4 years). Conclusion: Current evidence from phase 1–3 trials demonstrates that ex vivo gene editing can achieve functional cure for many patients with TDT and severe SCD. Conditioning-related toxicity, limited long-term safety data, and delivery complexity remain critical barriers to broader implementation.
- 13 January 2026
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 2 (1) , aubm012
Open AccessGene Editing Therapies for Sickle Cell Disease and β-Thalassemia: A Systematic Review of Clinical Outcomes and Safety
Background: Sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) remain major global health burdens. Ex vivo gene-editing therapies aim to achieve durable fetal hemoglobin (HbF) induction or direct mutation correction. Methods: We systematically reviewed clinical studies of CRISPR-Cas9 or base-editing therapies for SCD and TDT (MEDLINE, EMBASE, Web of Science, ClinicalTrials.gov, conference proceedings; 2010–03 December 2025). Eleven studies (>170 treated patients) reporting post-infusion outcomes were included. Results: All therapies produced robust, pancellular HbF (30–65%) and total hemoglobin in/near the normal range. In TDT (n > 100 evaluable), transfusion independence (≥12 months, Hb ≥9 g/dL) was achieved in 89–100% across platforms, sustained up to >4 years. In SCD (n > 60 evaluable), adjudicated vaso-occlusive crises were eliminated for ≥12 months in ≥97% of patients treated with exagamglogene autotemcel and 100% in smaller cohorts (EDIT-301, BEAM-101). No graft failures occurred. Serious adverse events and one death were attributable to busulfan conditioning, not editing. No therapy-related malignancies or confirmed harmful off-target edits have been reported, although follow-up remains limited (median ~18 months, longest >4 years). Conclusion: Current evidence from phase 1–3 trials demonstrates that ex vivo gene editing can achieve functional cure for many patients with TDT and severe SCD. Conditioning-related toxicity, limited long-term safety data, and delivery complexity remain critical barriers to broader implementation.
- 3 January 2026
- Published by IK Press in Journal of Disease and Global Health
- Vol. 19 (1) , 1-19
Establishing Multi-Ethnic, Globally Representative Biomarker Cohorts to Improve Early Detection and Diagnosis of Dementia
Global disparities in dementia diagnosis remain substantial, driven by unequal access to diagnostic tools, limited research infrastructure in low- and middle-income countries, and the persistent underrepresentation of non-European populations in dementia research. Drawing on evidence from major longitudinal cohorts, systematic reviews, population-based studies, and international research initiatives, this review examines how advances in cerebrospinal fluid, imaging, plasma, and digital biomarkers have reshaped early dementia detection. However, the validation of these biomarkers has relied predominantly on cohorts from high-income settings, limiting their generalizability and clinical accuracy in diverse populations. We synthesize evidence demonstrating that interacting genetic, metabolic, vascular, environmental, and sociocultural factors influence dementia risk at multiple biological levels from cellular and molecular pathways to systemic and cognitive phenotypes resulting in population-specific biomarker expression. These differences have direct clinical implications, including misclassification, delayed diagnosis, and inequitable access to biomarker-dependent therapies. The review highlights critical representation gaps in existing biomarker cohorts and discusses methodological challenges in global validation. Finally, we propose a framework for developing multi-ethnic, globally representative dementia biomarker cohorts through ethical governance, infrastructure investment in low- and middle-income countries, and the adoption of scalable plasma and digital biomarkers. Advancing biomarker equity is essential for improving diagnostic validity and building a globally inclusive dementia research and care ecosystem.
- 3 January 2026
- Published by IK Press in Journal of Disease and Global Health
- Vol. 19 (1) , 1-19
Establishing Multi-Ethnic, Globally Representative Biomarker Cohorts to Improve Early Detection and Diagnosis of Dementia
Global disparities in dementia diagnosis remain substantial, driven by unequal access to diagnostic tools, limited research infrastructure in low- and middle-income countries, and the persistent underrepresentation of non-European populations in dementia research. Drawing on evidence from major longitudinal cohorts, systematic reviews, population-based studies, and international research initiatives, this review examines how advances in cerebrospinal fluid, imaging, plasma, and digital biomarkers have reshaped early dementia detection. However, the validation of these biomarkers has relied predominantly on cohorts from high-income settings, limiting their generalizability and clinical accuracy in diverse populations. We synthesize evidence demonstrating that interacting genetic, metabolic, vascular, environmental, and sociocultural factors influence dementia risk at multiple biological levels from cellular and molecular pathways to systemic and cognitive phenotypes resulting in population-specific biomarker expression. These differences have direct clinical implications, including misclassification, delayed diagnosis, and inequitable access to biomarker-dependent therapies. The review highlights critical representation gaps in existing biomarker cohorts and discusses methodological challenges in global validation. Finally, we propose a framework for developing multi-ethnic, globally representative dementia biomarker cohorts through ethical governance, infrastructure investment in low- and middle-income countries, and the adoption of scalable plasma and digital biomarkers. Advancing biomarker equity is essential for improving diagnostic validity and building a globally inclusive dementia research and care ecosystem.
- Open Access
- 28 November 2025
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 1 (2) , aubm010
A Systematic Review of Augmented and Virtual Reality for STEM Learning: Engagement, Cognitive Load, and Transfer Outcomes
Immersive technologies such as augmented reality (AR) and virtual reality (VR) are increasingly used in science, technology, engineering, and mathematics (STEM) education, yet their effects on student engagement, cognitive load, and transfer of learning remain fragmented. This systematic review synthesized empirical research on AR and VR in STEM learning environments to examine how these technologies influence behavioral, emotional, and cognitive engagement; intrinsic, extraneous, and germane cognitive load; and near- and far-transfer outcomes. Following PRISMA 2020 guidelines, we searched major education and psychology databases for studies involving AR/VR STEM interventions with quantified engagement, cognitive load, or transfer measures. Twenty studies met the inclusion criteria. Across the sample, immersive technologies consistently enhanced student engagement, particularly by increasing interest, enjoyment, and time-on-task, although effects on deeper cognitive engagement were more variable. Augmented reality frequently reduced extraneous cognitive load by integrating digital information directly into physical learning tasks, whereas fully immersive virtual reality sometimes increased overall mental effort when environments were perceptually rich or navigation demands were high. Transfer of learning outcomes was generally positive but modest: most studies reported gains in near transfer, defined here as applying what was learned to tasks or problems that closely resemble the original learning context, while evidence for far transfer, defined as applying learning to novel, more complex, or substantially different situations, was limited and inconsistently assessed. Taken together, the findings indicate that immersive technologies most reliably improve student engagement and near-transfer learning in STEM when instructional design deliberately manages cognitive load, rather than relying on immersion alone to produce learning gains. These results underscore the importance of aligning immersive features with targeted learning goals and providing structured guidance and reflection to support meaningful transfer of learning.
- 28 November 2025
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 1 (2) , aubm010
Open AccessA Systematic Review of Augmented and Virtual Reality for STEM Learning: Engagement, Cognitive Load, and Transfer Outcomes
Immersive technologies such as augmented reality (AR) and virtual reality (VR) are increasingly used in science, technology, engineering, and mathematics (STEM) education, yet their effects on student engagement, cognitive load, and transfer of learning remain fragmented. This systematic review synthesized empirical research on AR and VR in STEM learning environments to examine how these technologies influence behavioral, emotional, and cognitive engagement; intrinsic, extraneous, and germane cognitive load; and near- and far-transfer outcomes. Following PRISMA 2020 guidelines, we searched major education and psychology databases for studies involving AR/VR STEM interventions with quantified engagement, cognitive load, or transfer measures. Twenty studies met the inclusion criteria. Across the sample, immersive technologies consistently enhanced student engagement, particularly by increasing interest, enjoyment, and time-on-task, although effects on deeper cognitive engagement were more variable. Augmented reality frequently reduced extraneous cognitive load by integrating digital information directly into physical learning tasks, whereas fully immersive virtual reality sometimes increased overall mental effort when environments were perceptually rich or navigation demands were high. Transfer of learning outcomes was generally positive but modest: most studies reported gains in near transfer, defined here as applying what was learned to tasks or problems that closely resemble the original learning context, while evidence for far transfer, defined as applying learning to novel, more complex, or substantially different situations, was limited and inconsistently assessed. Taken together, the findings indicate that immersive technologies most reliably improve student engagement and near-transfer learning in STEM when instructional design deliberately manages cognitive load, rather than relying on immersion alone to produce learning gains. These results underscore the importance of aligning immersive features with targeted learning goals and providing structured guidance and reflection to support meaningful transfer of learning.
- 15 April 2025
- Published by IK Press in Journal of Case Reports in Medical Science
- Vol. 11 (1) , 39-45
Physiotherapy and Functional Recovery in a Rare Case of Herpes Simplex Encephalitis
Background: Herpes simplex encephalitis (HSE) is the most common cause of sporadic viral encephalitis. It typically presents with fever, seizures, and altered mental status. If untreated, mortality can reach 70%, and among survivors, 20–60% experience long-term cognitive or functional impairment. Case Study: A 49-year-old female with well-controlled hypertension presented with sudden quadriparesis and aphasia, initially raising concern for a cerebrovascular event. However, her course evolved atypically for stroke, with progressive confusion, seizures, and cognitive decline. MRI showed temporal lobe hyperintensities, and CSF PCR confirmed HSV-1 infection, establishing herpes simplex virus encephalitis. Following acute medical management, she received an eight-week structured physiotherapy and cognitive rehabilitation program. Interventions included gait and balance training, strengthening, and functional retraining. Outcome measures such as Mini-Mental State Examination (MMSE), Berg Balance Scale (BBS), Dynamic Gait Index (DGI), and Barthel Index (BI) demonstrated marked improvements in mobility, independence, and cognition. Conclusion: This case highlights the diagnostic challenge of HSE, which can mimic stroke and Parkinsonism, while also demonstrating the potential of structured physiotherapy to achieve meaningful functional and cognitive recovery. The co-occurrence of acute cognitive changes, motor deficits, and behavioral disturbances with temporal lobe MRI abnormalities should alert clinicians to this potentially treatable disease, particularly in regions with limited diagnostic resources.
- 15 April 2025
- Published by IK Press in Journal of Case Reports in Medical Science
- Vol. 11 (1) , 39-45
Physiotherapy and Functional Recovery in a Rare Case of Herpes Simplex Encephalitis
Background: Herpes simplex encephalitis (HSE) is the most common cause of sporadic viral encephalitis. It typically presents with fever, seizures, and altered mental status. If untreated, mortality can reach 70%, and among survivors, 20–60% experience long-term cognitive or functional impairment. Case Study: A 49-year-old female with well-controlled hypertension presented with sudden quadriparesis and aphasia, initially raising concern for a cerebrovascular event. However, her course evolved atypically for stroke, with progressive confusion, seizures, and cognitive decline. MRI showed temporal lobe hyperintensities, and CSF PCR confirmed HSV-1 infection, establishing herpes simplex virus encephalitis. Following acute medical management, she received an eight-week structured physiotherapy and cognitive rehabilitation program. Interventions included gait and balance training, strengthening, and functional retraining. Outcome measures such as Mini-Mental State Examination (MMSE), Berg Balance Scale (BBS), Dynamic Gait Index (DGI), and Barthel Index (BI) demonstrated marked improvements in mobility, independence, and cognition. Conclusion: This case highlights the diagnostic challenge of HSE, which can mimic stroke and Parkinsonism, while also demonstrating the potential of structured physiotherapy to achieve meaningful functional and cognitive recovery. The co-occurrence of acute cognitive changes, motor deficits, and behavioral disturbances with temporal lobe MRI abnormalities should alert clinicians to this potentially treatable disease, particularly in regions with limited diagnostic resources.
- 10 April 2025
- Published by IK Press in Journal of Medicine and Health Research
- Vol. 10 (2) , 387-397
Haemopoietic Effect of Telfairia occidentalis on the Expression Pattern of RUNX1 and MECOM mRNA
Background: RUNX1 and MECOM are transcription factors that help regulate haemopoiesis. They act as important regulators in the process of blood formation. Natural plant products such as Telfairia occidentalis (fluted pumpkin) are widely used in traditional medicine for the management of anaemia, yet their specific molecular effects on haemopoietic gene expression remain poorly explored. Aim: This study investigated how Telfairia occidentalis leaf extract affects the expression of RUNX1 and MECOM in rats with anaemia. Methods: Twenty-four male Wistar rats (180–220 g) were divided into four groups (n = 6). Treatments were administered daily for 28 days. Phenylhydrazine-induced anaemia model was used in test group, followed by 100mg/Kg treatment of Telfairia occidentalis leaf extract. At the end of the study, blood samples were collected for complete blood count (CBC), and total RNA was extracted from bone marrow cells. The expression of RUNX1 and MECOM mRNA was quantified using reverse transcription polymerase chain reaction (RT-PCR). One-way analysis of variance (ANOVA) was carried out for comparison of data across multiple experimental groups to ascertain significance Results: Administration of Telfairia occidentalis to anaemic rats significantly (p < 0.05) increased red blood cell count, haemoglobin concentration, and packed cell volume compared to the anaemia-only group. Telfairia occidentalis significantly increased RUNX1 (2.4-fold) and reduced MECOM (2.2-fold) compared with untreated anaemic rats (p < 0.05) when control group = 2.0. Interestingly, the extract-treated anaemic group demonstrated partial restoration of blood indices toward normal control values, while RUNX1 and MECOM expression were significantly higher than both the control and anaemia-only groups. These findings suggest that Telfairia occidentalis enhances both functional blood cell recovery and transcriptional activation of key haemopoietic regulators. Conclusion: Telfairia occidentalis leaf extract helps to improve blood production. Its effect may be linked to the activation of RUNX1 and MECOM genes. This supports its use in treating anaemia and shows it could be useful as a natural blood-boosting medicine.
- 10 April 2025
- Published by IK Press in Journal of Medicine and Health Research
- Vol. 10 (2) , 387-397
Haemopoietic Effect of Telfairia occidentalis on the Expression Pattern of RUNX1 and MECOM mRNA
Background: RUNX1 and MECOM are transcription factors that help regulate haemopoiesis. They act as important regulators in the process of blood formation. Natural plant products such as Telfairia occidentalis (fluted pumpkin) are widely used in traditional medicine for the management of anaemia, yet their specific molecular effects on haemopoietic gene expression remain poorly explored. Aim: This study investigated how Telfairia occidentalis leaf extract affects the expression of RUNX1 and MECOM in rats with anaemia. Methods: Twenty-four male Wistar rats (180–220 g) were divided into four groups (n = 6). Treatments were administered daily for 28 days. Phenylhydrazine-induced anaemia model was used in test group, followed by 100mg/Kg treatment of Telfairia occidentalis leaf extract. At the end of the study, blood samples were collected for complete blood count (CBC), and total RNA was extracted from bone marrow cells. The expression of RUNX1 and MECOM mRNA was quantified using reverse transcription polymerase chain reaction (RT-PCR). One-way analysis of variance (ANOVA) was carried out for comparison of data across multiple experimental groups to ascertain significance Results: Administration of Telfairia occidentalis to anaemic rats significantly (p < 0.05) increased red blood cell count, haemoglobin concentration, and packed cell volume compared to the anaemia-only group. Telfairia occidentalis significantly increased RUNX1 (2.4-fold) and reduced MECOM (2.2-fold) compared with untreated anaemic rats (p < 0.05) when control group = 2.0. Interestingly, the extract-treated anaemic group demonstrated partial restoration of blood indices toward normal control values, while RUNX1 and MECOM expression were significantly higher than both the control and anaemia-only groups. These findings suggest that Telfairia occidentalis enhances both functional blood cell recovery and transcriptional activation of key haemopoietic regulators. Conclusion: Telfairia occidentalis leaf extract helps to improve blood production. Its effect may be linked to the activation of RUNX1 and MECOM genes. This supports its use in treating anaemia and shows it could be useful as a natural blood-boosting medicine.
- 10 April 2025
- Published by IK Press in Journal of Medicine and Health Research
- Vol. 10 (2) , 350-360
The Ameliorative Effect of Curcumin in HIV Protease Inhibitor-Induced Dyslipidaemia in Wistar Albino Rats
Background: Although HIV protease inhibitors (PIs) are essential for antiretroviral therapy's viral suppression, they have also been closely linked to the emergence of dyslipidaemia and oxidative stress, two conditions that put patients at risk for cardiovascular problems. Curcumin is an active polyphenol in Curcuma longa, which has received increasing attention for its antioxidant, anti-inflammatory, and lipid-modulating properties, suggesting a potential role in mitigating drug-induced metabolic derangements. Aim: This study aimed to evaluate the ameliorative effects of curcumin on HIV PI–induced dyslipidaemia and oxidative stress in Wistar albino rats. Methods: Twenty-four adult male rats were randomized into four groups (n = 6): Control, Curcumin only (100 mg/kg), PI only (lopinavir 50 mg/kg + ritonavir 12.5 mg/kg), and PI + Curcumin (same PI regimen with curcumin supplementation introduced after two weeks of PI). Treatments were administered daily via oral gavage for six weeks. Serum lipid profile was analysed for total cholesterol, triglycerides, HDL-C, LDL-C, and TC/HDL ratio, while liver homogenates were assessed for oxidative stress markers including malondialdehyde (MDA), superoxide dismutase (SOD), catalase, and reduced glutathione (GSH). Results: Findings showed that PI treatment significantly (p<0.001) elevated lipid parameters, TC, TG, LDL-C, and TC/HDL ratio, and reduced HDL-C, while also increasing MDA and reducing antioxidant enzymes (all p<0.05). Curcumin co-treatment reversed these alterations, lowering TC and TG by ~15–20% and restoring antioxidant enzyme levels toward control values. Curcumin alone did not alter lipid or oxidative parameters. Conclusion: These findings demonstrate that curcumin may effectively mitigate PI-induced dyslipidaemia and oxidative stress, highlighting its potential as a safe adjunct to improve metabolic outcomes in HIV therapy. Further clinical research is warranted to validate these protective effects and to inform the integration of curcumin supplementation into comprehensive HIV care.
- 10 April 2025
- Published by IK Press in Journal of Medicine and Health Research
- Vol. 10 (2) , 350-360
The Ameliorative Effect of Curcumin in HIV Protease Inhibitor-Induced Dyslipidaemia in Wistar Albino Rats
Background: Although HIV protease inhibitors (PIs) are essential for antiretroviral therapy's viral suppression, they have also been closely linked to the emergence of dyslipidaemia and oxidative stress, two conditions that put patients at risk for cardiovascular problems. Curcumin is an active polyphenol in Curcuma longa, which has received increasing attention for its antioxidant, anti-inflammatory, and lipid-modulating properties, suggesting a potential role in mitigating drug-induced metabolic derangements. Aim: This study aimed to evaluate the ameliorative effects of curcumin on HIV PI–induced dyslipidaemia and oxidative stress in Wistar albino rats. Methods: Twenty-four adult male rats were randomized into four groups (n = 6): Control, Curcumin only (100 mg/kg), PI only (lopinavir 50 mg/kg + ritonavir 12.5 mg/kg), and PI + Curcumin (same PI regimen with curcumin supplementation introduced after two weeks of PI). Treatments were administered daily via oral gavage for six weeks. Serum lipid profile was analysed for total cholesterol, triglycerides, HDL-C, LDL-C, and TC/HDL ratio, while liver homogenates were assessed for oxidative stress markers including malondialdehyde (MDA), superoxide dismutase (SOD), catalase, and reduced glutathione (GSH). Results: Findings showed that PI treatment significantly (p<0.001) elevated lipid parameters, TC, TG, LDL-C, and TC/HDL ratio, and reduced HDL-C, while also increasing MDA and reducing antioxidant enzymes (all p<0.05). Curcumin co-treatment reversed these alterations, lowering TC and TG by ~15–20% and restoring antioxidant enzyme levels toward control values. Curcumin alone did not alter lipid or oxidative parameters. Conclusion: These findings demonstrate that curcumin may effectively mitigate PI-induced dyslipidaemia and oxidative stress, highlighting its potential as a safe adjunct to improve metabolic outcomes in HIV therapy. Further clinical research is warranted to validate these protective effects and to inform the integration of curcumin supplementation into comprehensive HIV care.